RE:Material Amount Relative to the size of the losses the $9M number is not really too significant BUT what's brought me back and what I do think is material is the nr gives me confidence that the demand for and the standing of PLI"s products in a very closed sector is high. As such the path to acceptance of pending products has been cleared meaning to me that PLI does not have to prove itself as a reliable supplier and sp will pop significantly with FDA approvals now in advanced stages and commercial plasminogen production. I recently sold PLI for a nice gain but I'm thinking now that I will start rebuilding my position. IMHO of course.